Adequacy of biopsy samples for epidermal growth factor receptor (EGFR) molecular testing in lung adenocarcinoma
Background/Aim. Adenocarcinoma of the lung is the most common histological type of lung cancer. The most reliable method in detecting epidermal growth factor receptor (EGFR) mutations is real-time polymerase chain reaction (PCR). It is recommended to sample three to five biopsy samples with a minimu...
Main Authors: | Tegeltija Dragana, Lovrenski Aleksandra, Vasiljević Tijana, Andrejić-Višnjić Bojana |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2021-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900083T.pdf |
Similar Items
-
Association between epidermal growth factor receptor mutation status, clinicopathological characteristics and TTF-1 expression in lung adenocarcinoma: A single center study
by: Tegeltija Dragana, et al.
Published: (2021-01-01) -
The Factors Predicting Concordant Epidermal Growth Factor Receptor (EGFR) Mutation Detected in Liquid/Tissue Biopsy and the Related Clinical Outcomes in Patients of Advanced Lung Adenocarcinoma with <i>EGFR</i> Mutations
by: Chia-Yu Kuo, et al.
Published: (2019-10-01) -
Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007) -
Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007) -
Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007)